The parents of a little boy on life support have launched a campaign to raise £1.2 million, so their son can receive specialist treatment in the US.
Charlie’s mother, Connie Yates, launched the #CharliesFight campaign on the crowdfunding site gofundme.com, which has now received £250,024.
Charlie Gard was born with a rare genetic condition called mitochondrial depletion syndrome, which causes a progressive muscle weakness shortly after the child’s birth. Charlie was admitted to Great Ormond Street Hospital 8 weeks after he was born, and has since remained under 24-hour care on the intensive care unit.
Miss Yates and Charlie’s father, Chris Gard, had to take Great Ormond Street Hospital to the High Court, after the hospital wanted to take their son off life support.
Kate Gallop QC, the barrister representing doctors at Great Ormond Street, said the hospital’s specialist had considered the type of treatment available in the US and decided not to adopt it.
Credit:
Submitted Article
Headline
Short Headline
Standfirst
Published Article
HeadlineParents appeal for £1 million donation to save son’s life
Short Headline
Standfirst
The parents of a little boy on life support have launched a campaign to raise £1.2 million, so their son can receive specialist treatment in the US.
Charlie’s mother, Connie Yates, launched the #CharliesFight campaign on the crowdfunding site gofundme.com, which has now received £250,024.
Charlie Gard was born with a rare genetic condition called mitochondrial depletion syndrome, which causes a progressive muscle weakness shortly after the child’s birth. Charlie was admitted to Great Ormond Street Hospital 8 weeks after he was born, and has since remained under 24-hour care on the intensive care unit.
Miss Yates and Charlie’s father, Chris Gard, had to take Great Ormond Street Hospital to the High Court, after the hospital wanted to take their son off life support.
Kate Gallop QC, the barrister representing doctors at Great Ormond Street, said the hospital’s specialist had considered the type of treatment available in the US and decided not to adopt it.
